LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference
September 01 2020 - 4:23PM
Business Wire
LabCorp (NYSE: LH) today announced that members of the executive
management team will participate in a virtual fireside chat at the
Baird’s 2020 Global Healthcare Conference on Wednesday, Sept. 9 at
11:25 a.m. ET.
About LabCorp LabCorp (NYSE: LH), an S&P 500 company,
is a leading global life sciences company that is deeply integrated
in guiding patient care, providing comprehensive clinical
laboratory and end-to-end drug development services. With a mission
to improve health and improve lives, LabCorp delivers world-class
diagnostic solutions, brings innovative medicines to patients
faster, and uses technology to improve the delivery of care.
LabCorp reported revenue of more than $11.5 billion in 2019. To
learn more about LabCorp, visit www.LabCorp.com, and to learn more
about LabCorp’s drug development business, Covance, visit
www.Covance.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including
but not limited to statements with respect to the impact of various
factors on operating and financial results and the opportunities
for future growth. Each of the forward-looking statements is
subject to change based on various important factors, many of which
are beyond the Company’s control, including without limitation, the
impact of the COVID-19 pandemic on our business and financial
condition as well as on general economic, business, and market
conditions, competitive actions and other unforeseen changes and
general uncertainties in the marketplace, changes in government
regulations, including healthcare reform, customer purchasing
decisions, including changes in payer regulations or policies,
other adverse actions of governmental and third-party payers, the
Company’s satisfaction of regulatory and other requirements,
patient safety issues, changes in testing guidelines or
recommendations, federal, state, and local governmental responses
to the COVID-19 pandemic, adverse results in material litigation
matters, failure to maintain or develop customer relationships, our
ability to develop or acquire new products and adapt to
technological changes, failure in information technology, systems
or data security, changes in business conditions and the economy in
general, adverse weather conditions, the number of revenue days in
a financial period, employee relations, personnel costs, and effect
of exchange rate fluctuations. These factors, in some cases, have
affected and in the future (together with other factors) could
affect the Company’s ability to implement the Company’s business
strategy and actual results could differ materially from those
suggested by these forward-looking statements. As a result, readers
are cautioned not to place undue reliance on any of our
forward-looking statements. The Company has no obligation to
provide any updates to these forward-looking statements even if its
expectations change. All forward-looking statements are expressly
qualified in their entirety by this cautionary statement. Further
information on potential factors, risks and uncertainties that
could affect operating and financial results is included in the
Company’s most recent Annual Report on Form 10-K and subsequent
Forms 10-Q, including in each case under the heading RISK FACTORS,
and in the Company’s other filings with the SEC.
# # #
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901006059/en/
Investors: Clarissa Willett - 336-436-5076
Investor@LabCorp.com
Media: Pattie Kushner - 336-436-8263 Media@LabCorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2024 to May 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From May 2023 to May 2024